Gyl Financial Synergies »

SPDR S&P Biotech shares owned by Gyl Financial Synergies

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Gyl Financial Synergies from 13F filings

Historical chart of Gyl Financial Synergies investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Gyl Financial Synergies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Gyl Financial Synergies

Quarter filed Position value Share count Share price at filing
2023-12-31 $224k 2.5k 89.29
2023-09-30 $230k 3.1k 73.02
2023-06-30 $265k 3.2k 83.20
2023-03-31 $243k 3.2k 76.21

More positions owned by Gyl Financial Synergies

Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Ishares Tr Core Total Usd (IUSB)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Emrg Chn (EMXC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Cohen Steer Reit (ICF)
Procter & Gamble Company (PG)
Goldman Sachs (GS)
Ishares Tr Us Sml Cap Eqt (SMLF)

View all positions for Gyl Financial Synergies

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Susquehanna International
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors

View all funds holding SPDR S&P Biotech